DexCom, Inc. , the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the first CGM manufacturer to integrate GenAI into ...
The global self-monitoring blood glucose devices market was valued at $8,490.79 million in 2019, and is projected to reach $11,991.98 million by 2027, growing at a CAGR of 4.2% from 2020 to 2027.
For recording the units of energy consumed at particular hours, smart meters are required. Currently, only around 50,000 consumers in the city, where there are close to 5 lakh domestic consumers ...